Cyclic dinucleotides useful for the treatment of inter alia cancer
A compound of formula (I) or a pharmaceutically acceptable salt and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases and conditions in which modulation of STING (Stimulator of Interferon Genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious diseases, cancer, pre-cancerous syndromes and as vaccine adjuvants.
1. A compound of formula (I)
wherein
R 1 is OH and R 2 is NH 2 or R 1 is NH 2 and R 2 is H;
R 3 is OH and R 4 is NH 2 or R 3 is NH 2 and R 4 is H;
One of R 5 and R 6 is F, the other is F or OH,
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof according to claim 1 and one or more of pharmaceutically acceptable excipients.
3. A combination comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof according to claim 1 and at least one further therapeutic agent.
4. A compound of claim 1 which is:
or a pharmaceutically acceptable salt thereof.
5. A compound of claim 4 which is:
6. A pharmaceutically acceptable salt of a compound of claim 4 which is:
7. A compound of claim 1 which is:
or a pharmaceutically acceptable salt thereof.
8. A compound of claim 7 which is:
9. A pharmaceutically acceptable salt of a compound of claim 7 which is: